Type 2 Diabetes Mellitus:: An Evidence-Based Approach to Practical Management

Mark N. Feinglos

ISBN 10: 161737783X / ISBN 13: 9781617377839

Published by SPRINGER NATURE Nov 2010, 2010

About this Item

This item is printed on demand - it takes 3-4 days longer - Neuware -In this practical book, the authors of each chapter have synthesized the currently available evidence regarding specific issues in diabetes care. The chapters have been written by an interdisciplinary team of scientists and medical professionals. Such an approach emphasizes the need for collaboration in the care of any individual with diabetes and in the effort to find new therapies for the disease. This reference provides practical guidance in a single resource. 474 pp. Englisch.

Seller Inventory # 9781617377839

Bibliographic Details

• Title: Type 2 Diabetes Mellitus:: An Evidence-Based Approach to Practical Management
• Publisher: SPRINGER NATURE Nov 2010
• Publication Date: 2010
• Language: English
• ISBN 10: 161737783X
• ISBN 13: 9781617377839
• Binding: Taschenbuch
• Condition: Neu
• Dimensions: 282W x 212H x 37D millimeters 282 millimeters width by 212 millimeters height by 37 millimeters depth
• Weight: 1101 grams

About this title

Synopsis

As the global epidemic of diabetes continues to expand, the prevalence of type 2 diabetes is predicted to double in the next 20 years. Type 2 Diabetes Mellitus: An Evidence-Based Approach to Practical Management addresses this problem by expertly synthesizing the currently available evidence regarding specific issues in diabetes care. Written by an interdisciplinary team of scientists and medical professionals and comprising a wealth of information in a single resource, the book integrates the best evidence for the full range of clinical issues surrounding the evaluation and treatment of type 2 diabetes, including comorbid conditions such as hypertension, hyperlipidemia, and vascular disease. To quantify the strength of evidence supporting current practices, each chapter highlights related conditions, including fatty liver disease, pregnancy, and polycystic ovarian syndrome, and also addresses barriers to treatment, including stress, depression, and patient motivation.